194 related articles for article (PubMed ID: 16566599)
1. Mechanism of the membrane interaction of polynuclear platinum anticancer agents. Implications for cellular uptake.
Liu Q; Qu Y; Van Antwerpen R; Farrell N
Biochemistry; 2006 Apr; 45(13):4248-56. PubMed ID: 16566599
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines.
Roberts JD; Peroutka J; Beggiolin G; Manzotti C; Piazzoni L; Farrell N
J Inorg Biochem; 1999 Oct; 77(1-2):47-50. PubMed ID: 10626353
[TBL] [Abstract][Full Text] [Related]
3. Cellular pharmacology of polynuclear platinum anti-cancer agents.
Roberts JD; Peroutka J; Farrell N
J Inorg Biochem; 1999 Oct; 77(1-2):51-7. PubMed ID: 10626354
[TBL] [Abstract][Full Text] [Related]
4. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.
Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N
Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899
[TBL] [Abstract][Full Text] [Related]
5. Differences in the cellular response and signaling pathways of cisplatin and BBR3464 ([[trans-PtCl(NH3)(2)]2mu-(trans-Pt(NH3)(2)(H2N(CH2)(6)-NH2)2)]4+) influenced by copper homeostasis.
Kabolizadeh P; Ryan J; Farrell N
Biochem Pharmacol; 2007 May; 73(9):1270-9. PubMed ID: 17234160
[TBL] [Abstract][Full Text] [Related]
6. Structural Factors Affecting Binding of Platinum Anticancer Agents with Phospholipids: Influence of Charge and Phosphate Clamp Formation.
Gorle AK; Zhang J; Liu Q; Berners-Price SJ; Farrell NP
Chemistry; 2018 Mar; 24(18):4643-4652. PubMed ID: 29341369
[TBL] [Abstract][Full Text] [Related]
7. Sequence-dependent conformational changes in DNA induced by polynuclear platinum complexes.
McGregor TD; Balcarová Z; Qu Y; Tran MC; Zaludová R; Brabec V; Farrell N
J Inorg Biochem; 1999 Oct; 77(1-2):43-6. PubMed ID: 10626352
[TBL] [Abstract][Full Text] [Related]
8. Translesion DNA synthesis across double-base lesions derived from cross-links of an antitumor trinuclear platinum compound: primer extension, conformational and thermodynamic studies.
Novakova O; Farrell NP; Brabec V
Metallomics; 2018 Jan; 10(1):132-144. PubMed ID: 29242879
[TBL] [Abstract][Full Text] [Related]
9. Possible biotransformation reactions of polynuclear Pt(II) complexes.
Summa N; Maigut J; Puchta R; van Eldik R
Inorg Chem; 2007 Mar; 46(6):2094-104. PubMed ID: 17311374
[TBL] [Abstract][Full Text] [Related]
10. Pre-association of polynuclear platinum anticancer agents on a protein, human serum albumin. Implications for drug design.
Montero EI; Benedetti BT; Mangrum JB; Oehlsen MJ; Qu Y; Farrell NP
Dalton Trans; 2007 Nov; (43):4938-42. PubMed ID: 17992278
[TBL] [Abstract][Full Text] [Related]
11. Biological consequences of trinuclear platinum complexes: comparison of [[trans-PtCl(NH3)2]2mu-(trans-Pt(NH3)2(H2N(CH2)6-NH2)2)]4+ (BBR 3464) with its noncovalent congeners.
Harris AL; Ryan JJ; Farrell N
Mol Pharmacol; 2006 Feb; 69(2):666-72. PubMed ID: 16275707
[TBL] [Abstract][Full Text] [Related]
12. Competitive formation of DNA linkage isomers by a trinuclear platinum complex and the influence of pre-association.
Moniodis JJ; Thomas DS; Davies MS; Berners-Price SJ; Farrell NP
Dalton Trans; 2015 Feb; 44(8):3583-3593. PubMed ID: 25407024
[TBL] [Abstract][Full Text] [Related]
13. Studies on synthesis, activity and binding with DNA of a new trinuclear platinum compound [{trans-PtCl(NH3)2}2{trans-Pt(thiazole)2}{H2N(CH2)(6NH2}2]Cl3(NO3).
Al-Shuneigat J; Qing Y; Beale P; Fisher K; Huq F
Med Chem; 2011 Jan; 7(1):1-8. PubMed ID: 21235513
[TBL] [Abstract][Full Text] [Related]
14. DNA condensing effects and sequence selectivity of DNA binding of antitumor noncovalent polynuclear platinum complexes.
Malina J; Farrell NP; Brabec V
Inorg Chem; 2014 Feb; 53(3):1662-71. PubMed ID: 24428232
[TBL] [Abstract][Full Text] [Related]
15. Substitution-inert polynuclear platinum complexes and Glycosaminoglycans: A molecular dynamics study of its non-covalent interactions.
Rosa NMP; Ferreira FHDC; Farrell NP; Costa LAS
J Inorg Biochem; 2022 Jul; 232():111811. PubMed ID: 35367819
[TBL] [Abstract][Full Text] [Related]
16. Reaction of polynuclear platinum antitumor compounds with reduced glutathione studied by multinuclear (1H, 1H-15N gradient heteronuclear single-quantum coherence, and 195Pt) NMR spectroscopy.
Oehlsen ME; Qu Y; Farrell N
Inorg Chem; 2003 Sep; 42(18):5498-506. PubMed ID: 12950196
[TBL] [Abstract][Full Text] [Related]
17. Deoxyribonuclease I footprinting reveals different DNA binding modes of bifunctional platinum complexes.
Chválová K; Kaspárková J; Farrell N; Brabec V
FEBS J; 2006 Aug; 273(15):3467-78. PubMed ID: 16824042
[TBL] [Abstract][Full Text] [Related]
18. Consequences of nucleic acid conformation on the binding of a trinuclear platinum drug.
Kloster MB; Hannis JC; Muddiman DC; Farrell N
Biochemistry; 1999 Nov; 38(45):14731-7. PubMed ID: 10555954
[TBL] [Abstract][Full Text] [Related]
19. Insights into the molecular mechanisms of protein platination from a case study: the reaction of anticancer platinum(II) iminoethers with horse heart cytochrome c.
Casini A; Gabbiani C; Mastrobuoni G; Pellicani RZ; Intini FP; Arnesano F; Natile G; Moneti G; Francese S; Messori L
Biochemistry; 2007 Oct; 46(43):12220-30. PubMed ID: 17924668
[TBL] [Abstract][Full Text] [Related]
20. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.
Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N
J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
